Human endothelial-like differentiated precursor cells maintain their endothelial characteristics when cocultured with mesenchymal stem cell and seeded onto human cancellous bone by Henrich, Dirk et al.
Hindawi Publishing Corporation
Mediators of Inflammation
Volume 2013, Article ID 364591, 12 pages
http://dx.doi.org/10.1155/2013/364591
Research Article
Human Endothelial-Like Differentiated Precursor Cells
Maintain Their Endothelial Characteristics When Cocultured
with Mesenchymal Stem Cell and Seeded onto Human
Cancellous Bone
Dirk Henrich, Kerstin Wilhelm, Joerg Warzecha, Johannes Frank, John Barker,
Ingo Marzi, and Caroline Seebach
Department of Trauma, Hand and Reconstructive Surgery, Johann Wolfgang Goethe University,
Theodor-Stern-Kai 7, 60590 Frankfurt, Germany
Correspondence should be addressed to Dirk Henrich; d.henrich@trauma.uni-frankfurt.de
Received 7 May 2012; Revised 20 December 2012; Accepted 3 January 2013
Academic Editor: Giuseppe Valacchi
Copyright © 2013 Dirk Henrich et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Introduction. Cancellous bone is frequently used for filling bone defects in a clinical setting. It provides favourable conditions for
regenerative cells such as MSC and early EPC. The combination of MSC and EPC results in superior bone healing in experimental
bone healing models. Materials and Methods. We investigated the influence of osteogenic culture conditions on the endothelial
properties of early EPC and the osteogenic properties of MSC when cocultured on cancellous bone. Additionally, cell adhesion,
metabolic activity, and differentiation were assessed 2, 6, and 10 days after seeding. Results. The number of adhering EPC and MSC
decreased over time; however the cells remained metabolically active over the 10-day measurement period. In spite of a decline of
lineage specific markers, cells maintained their differentiation to a reduced level. Osteogenic stimulation of EPC caused a decline
but not abolishment of endothelial characteristics and did not induce osteogenic gene expression. Osteogenic stimulation of MSC
significantly increased their metabolic activity whereas collagen-1𝗼 and alkaline phosphatase gene expressions declined. When
cocultured with EPC, MSC’s collagen-1𝗼 gene expression increased significantly. Conclusion. EPC and MSC can be cocultured
in vitro on cancellous bone under osteogenic conditions, and coculturing EPC with MSC stabilizes the latter’s collagen-1𝗼 gene
expression.
1. Introduction
Autologous cell transplantation is a promising treatment
option for large bone defects as it eliminates problems
such as limited autologous bone availability, allogenic bone
immunogenicity, and donor site morbidity and could be
used for stabilizing loose alloplastic implant [1, 2]. Marrow-
derived stromal cells (MSCs) alone and in combination with
endothelial progenitor cells (EPCs) have been shown to
promote bone healing in a variety of different settings [3–5].
The bone formation was shown to be improved when
MSCs were preconditioned with osteogenic substances
such as ascorbic acid and dexamethasone [6]. Another
study demonstrated an enhanced callus formation after
transplantation of osteogenic predifferentiated MSC during
distraction osteogenesis in 3 patients [7]. In an animal study
dexamethasone-pretreatedMSCseededonacollagensponge
resultinasignificanthighermineralizationofthecollagenous
matrix.Themineralizationcouldbeclearlyascertainedtothe
transplanted cells [8].
Improved bone healing has also been described in the
presence of EPC. This effect has been attributed to EPC
stimulation of early vascularization, a prerequisite for in
vivo bone regeneration [9]. At least two major types of
endothelial cell lines can be obtained by in vitro culture
of mononuclear cells: first, the so-called “endothelial-like
cells” or “early EPC” and, second, the so-called “outgrowth
EPC” or “late EPC”. Early EPCs are derived presumably from
monocytic/dendritic precursors, and some authors there-
fore designate them as endothelial-like differentiated PBMC2 Mediators of Inflammation
[10, 11]. Those cells can be generated in a sufficient amount
within 3 to 5 days from a reasonable volume of blood [12].
Early EPCs are potent producers of vascular endothelial
growth factor (VEGF) [13].
WhentransplantingMSCand/orEPCintobonedefects,a
scaffold is needed. Synthetic or processed bone-graft substi-
tutes should be osteoinductive, enabling the osteogenic dif-
ferentiation of cells, should provide appropriate mechanical
stability, should permit the ingrowth of cells and vessels [14]
thereby improving bone regeneration [15] ,a n ds h o u l db e
resorbable. Various porous ceramics are currently available
[16]. Hydroxyapatite (HA) sintered ceramics are widely used
due to their osteoconductivity but their bioresorbability
are comparatively low. In contrast, tricalcium phosphate
(TCP) ceramics were porous, resorbable, and biocompatible
materials. They do not provoke an inflammatory response
and permit the ingrowth of cells and vessels [17]d u r i n gb o n e
regeneration. Furthermore, TCP can be completely substi-
tuted for the bone tissue after stimulation of bone formation.
Also the surface chemistry of the scaffold influences the
behaviour, through either the influence of its charge density
or atomic array on adherent or passing cell populations [18].
Moreover, the surface charge of the biomaterials influences
thebindingofmatrixproteinsorgrowthfactors,whichmight
also influence the cell behaviour locally [19].
Bone allografts consist of a collagen fibre network with
attached hydroxyapatite crystals providing elasticity and
perhaps osteoconductive properties to these scaffolds [20].
Those materials do not evoke any appreciable foreign-body
immunogenic reaction. Although antigenic structures were
destroyed during processing components of the extracellular
matrix, various growth factors such as bone morphogenetic
protein-2 (BMP-2) remain functionally active [21, 22].
Bone graft substitutes are well described physically and
chemically [23] as an osteoconductive scaffold, but even
more of interest are biological properties like cell adhesion
and function of processed and synthetic biomaterials as
delivery system for bone tissue engineering in critical size
defects. However, depending on the method used to process
t h eb o n ea l l o g r a ft st h ea c t i v e( o s t e o i n d u c t i v e )a n dp a s s i v e
(osteoconductive) biologic interaction between the scaffold
and the transplanted cells may vary and greatly influence
the proliferation of the latter [24]. This was proved in a
comparative study in which a markedly increased survival
and metabolic activity of MSC on human cancellous bone
(Tutoplast) incomparisonto fivedifferent syntheticmaterials
were observed [20].
Recently itwasshownthatEPCandMSCcan besuccess-
fully grafted onto a 𝗽-TCP-matrix [25]; however, little data
existsregardingthesurvival,proliferation,anddifferentiation
of these cells when seeded on human cancellous bone
(Tutoplast).
A beneficial effect on bone healing mediated by osteo-
genicpreconditionedMSChasbeenrepeatedlydescribed[6–
8] .B u tt h ee ff e c to ft h eo s t e o g e n i cc o n d i t i o n so ne a r l yE P C
hasnotbeenaddressed.Moreover,theinfluenceofosteogenic
culture conditions on the number, metabolic activity, and
differentiation of early EPC alone or in coculture with MSC
has not been addressed yet.
I nt h ep r e s e n ts t u d yw ei n v e s t i g a t e dt h ei n fl u e n c eo f
osteogenic culture conditions on the endothelial properties
of human early EPC seeded alone on human cancellous bone
chips and together with human MSC.
2. Materials and Methods
2.1.Isolation,Cultivation,andCharacterizationofMSC. Bone
marrow cells were obtained from iliac crest aspirates of
volunteer trauma patients (𝑛=5 ) undergoing pelvic surgery
[26]. This was performed in accordance with and with the
approval of our hospital’s ethics committee. All patients
signed informed consent. Briefly, MSCs were isolated from
fresh bone marrow aspirate using Ficoll density gradient
centrifugation (30min, 1100g, 𝑑 = 1,077g/mL, Biochrom,
Berlin, Germany). Cells in the interphase were collected,
washed twice with PBS containing 2% fetal bovine serum
(FBS) (10min, 900g), resuspended in 3mL MesenCult +
Supplements (Cell-Systems, St. Katharinen, Germany), and
were counted using a Neubauer chamber. 4 × 10
6 cells were
seeded in a 25cm
2 culture flask and then expanded over
t h r e et ofi v ep a s s a g e sp r i o rt ob e i n gu s e di nt h ep r e s e n t
experiments. Cells were detached by 10min incubation with
Accutase, then washed (10min, 300g), re-suspended in
MesenCult + Supplements, and divided in 2 parts. One
part was adjusted to a density of 2.5 × 10
5 cells in 100𝜇L
and used for the present experiments, and the other was
used for confirmation of MSC, surface characteristics using
flow cytometry (FACSCalibur, BD-Biosciences, Heidelberg,
Germany). MSCs were negative for CD45 and CD34 and
express CD73, CD90, and CD105 as described previously; all
antibodies were purchased from BD-Biosciences [26].
2.2. Isolation, Identification, and Characterization of Early
EPC. EPCs were isolated according to procedures described
elsewhere [25, 27]. Briefly, PBMCs were isolated from
buffy coat (𝑛=5 ) by density gradient centrifugation
(20min, 600g) with Ficoll (1.077g/mL, Biochrom, Berlin,
Germany).PBMCswerewashedtwicewithcoldPBSwithout
Ca
2+ and Mg
2+ (PBS
w/o, 10min, 350g), and 4 ∗ 10
6 cells
were cultivated on a fibronectin-coated (10𝜇g/mL, Sigma,
Deisenhofen, Germany) 24-well culture dish in 1mL of
endothelial basal medium (EBM2, Cambrex, Verviers,
Belgium) supplemented with EGM2 SingleQuots at 37
∘C,
5% CO2.A ft e r4 8h r s ,n o n -a n dw e a k l ya d h e r e n tc e l l sw e r e
removed, the medium was exchanged, and the cells were
cultivated for an additional 72hrs. A parallel preparation
was performed to evaluate the percentage of endothelial
cell-like differentiated cells. Cells were incubated for 1h
with 2.4𝜇g/mL 1,1
򸀠-dioctadecyl-3,3,3
򸀠,3
򸀠-tetramethylindo-
carbocyanine-labeled acetylated low-density lipoprotein
(DiLDL, CellSystems, St. Katharinen, Germany) in EBM
supplemented with 20% FCS. Cells were fixed with 2%
paraformaldehyde for 10min, and after washing with PBS
+/+
FITC-labelled Ulex europaeus agglutinin-1 [10𝜇g/mL]
(lectin, Sigma, Deisenhofen, Germany) was incubated for
1h. Cells presenting double-positive fluorescence were
considered to be EPC. Only preparations with a percentageMediators of Inflammation 3
of endothelial like differentiated cells of greater than 80%
were used. For the determination of the expression of the
endothelialmarkers CD31 andvonWillebrandtfactor(vWF)
av o l u m eo f1 0 0 𝜇L DiLDL prestained cells was incubated
for 20min with either monoclonal antibody against vWF
(Dako, Hamburg, Germany) followed by 15min incubation
with a FITC conjugated secondary antibody (Dako) or
with a FITC-conjugated monoclonal antibody against CD31
(Chemikon, Hofheim, Germany). Antibodies of identical
isotypes served as control. After two steps of washing, the
cells were subjected to flow cytometry using a FACSCalibur
(BD Biosciences).
Cellsweredetachedbyincubation(10min)withAccutase
(PAA Laboratories, Linz, Austria), washed once with Mesen-
Cult+Supplements(Cell-Systems,St.Katharinen,Germany)
a n dt h e na d j u s t e dt oad e n s i t yo f2.5 × 10
5 cells in 100𝜇L.
2.3. Human-Processed Cancellous Bone (Tutoplast). Ap r o -
cessed human cancellous bone allograft material (Tutoplast,
TutogenMedical)wasused.Thesolventpreserved,dried,and
gamma-irradiated material has a particle size of 0.5–2mm
with a pore size ranging from 100 to 500𝜇m. The material
has a high mechanical stability and a rapid biodegradability
(information provided by the manufacturer).
2.4. Seeding Cells on Scaffold. Tutoplast granules were placed
as a dense single layer in a 24-well plate (Nunc, Wiesbaden,
Germany) using sterile forceps and prewetted with 200𝜇L
PBS with Ca
2+ and Mg
2+ (PBS
+/+). 5×1 0
5 MSCs or EPCs
in a volume of 200𝜇Lw e r ed r i p p e do n t ot h eTutoplast layer
and were incubated for 10min at 37
∘C. When MSC together
with EPCs were tested, 2.5 × 10
5 cells of each were mixed
immediately prior to seeding.
After incubation, a medium containing the nonadher-
ing cells was removed and dripped once again over the
Tutoplast layer, followed by incubation as indicated above.
This procedure was repeated three times. The granules were
then gently transferred to another well containing 500𝜇L
of a mixture consisting of 2 parts Mesencult + supplements
and 1 part EBM2+EGM2 Singlequots.B e l o wt h i sm i x t u r ei s
referred to as the “medium” and is described in [25]. All
experiments were performed using the said medium. The
remaining cells in the supernatant and the bottom of the
initial seeding well were isolated, counted, and the percent-
age of adhering cells was calculated ((initial cell number −
remaining cell number)/initial cell number)∗100.
2.5. Identification of MSC and Early EPC on Tutoplast. MSC
and EPC, alone and combined, were seeded on Tutoplast
as described above. Approximately 4-5 granules were trans-
ferred to a single well of a 96-well plate using sterile forceps
andincubatedin100𝜇Lmediumforaperiodof2,6or10days
inaCO2 incubatorat37
∘C.Parallelpreparationsincludedthe
same as above with the addition of substances that promote
osteogenic differentiation: Dexamethasone [final concentra-
tion 1.0 × 10
−7 M], 𝗽-glycerolphosphate [final concentra-
tion 1.0 × 10
−2 M], and ascorbic acid [final concentration
5×1 0
−5 M] [6]. All substances were obtained from Sigma
(Deisenhofen, Germany). In order to detect MSC and EPC,
MSC 1𝜇L of DiLDL (CellSystem, St. Katharinen, Germany)
or 1𝜇LD A P I[ fi n a lc o n c e n t r a t i o n1𝜇g/mL] was added to the
corresponding wells followed by further incubation for 1h
at 37
∘C. After three washes with PBS
−/−,t h eg r a n u l e sw e r e
transferred to a new well in order to prevent false-positive
results caused by cells adhering to the bottom of the cultiva-
tion well. Finally, randomly chosen Tutoplast granules were
viewed at 100x magnification using fluorescence microscopy
(Zeiss, Axio Observer, Gottingen, Germany), and the
DiLDL-stained EPC and DAPI-stained MSC were counted
using cell explorer 2001 (BioScieTec, Frankfurt, Germany)
software.
2.6. Identification of EPC and MSC by Scanning Elec-
tron Microscopy (SEM). Tutoplast granules were seeded
with either MSC, EPC, or both. After 2 days the cell-
Tutoplast constructs were fixed in 2% glutaraldehyde in PBS
(Merck, Darmstadt, Germany) for 30min and dehydrated
by incubation for 15min in PBS with increasing concentra-
t i o n so fe t h a n o l( 2 5 % ,5 0 % ,7 5 % ,9 6 % ,a n d1 0 0 % ) .S u b s e -
quently the samples were incubated overnight in 1,1,1,3,3,3-
hexamethyldisilazane (Merck, Darmstadt, Germany) and
slowly air-dried. The granules were fixed with carbon glue
to an aluminium carrier and sputtered trice for each 1min
with gold (Agar Sputter Coater, Agar Scientific Ltd., UK)
and subjected to scanning electron microscopy. A Hitachi
FE-SEM S4500 was used (Hitachi, D¨ usseldorf, Germany).
A voltage of 5kV was applied. The images were digitally
recorded using the Digital Image Processing System 2.6 (Point
Electronic, Halle, Germany).
2.7. Cell-Tutoplast Adherence (MTT Assay). For determina-
tion of the metabolic activity as a correlate of the number of
cells adhering to the Tutoplast scaffold a Cell proliferation Kit
I (MTT, Roche Diagnostics, Mannheim, Germany) was used
following the manufacturer’s instructions. In brief, the MTT
assay is based on the cleavage of the yellow tetrazolium salt
MTT(3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium
bromide) to purple formazan crystals by metabolically active
cells. MSC obtained from 5 donors and EPC derived from
5 buffy coats were tested. The following combinations were
performed: MSC alone, EPC alone, and MSC and EPC
together. All experiments were performed in duplicate.
Cells were seeded on Tutoplast, as described above,
and 3 to 5 granules, depending on the granule’s size, were
t r a n s f e r r e dt on e ww e l l si na9 6 - w e l lp l a t e( N u n c ,R o s k i l d e ,
Denmark) and cultivated for 2, 6, and 10 days. Before adding
the MTT reagent, granules were transferred to an empty
well, in order to prevent false positive results caused by cells
adhering to the bottom of the well. 90𝜇Lo fm e d i u ma n d
10𝜇Lo fM T Tl a b e l l i n gr e a g e n tw e r ea d d e dt oe a c hw e l la n d
cells were incubated for an additional 4hrs. Next, the cells
were incubated overnight with a solubilization solution. The
supernatant was collected and transferred to another 96-
well plate. The absorbance at 570nm was then measured
with an ELISA reader (Ceres UV900c, Bio-Tek Instru-
ments,Windoski,VT,USA).Ascontrols,increasingnumbers4 Mediators of Inflammation
(1000, 2500, 5000, and 10.000) of MSC and EPC were seeded
directly in 96 well plates and assessed separately.
2.8. Expression of Osteogenic and Endothelial Marker Genes
by Real Time RT-PCR. In brief, total RNA was isolated using
the RNeasy system (Qiagen, Hilden, Germany) following
themanufacturer’sinstructionswiththefollowingexception.
Approximately 50 𝜇L Tutoplast-granules that had been sown
with progenitor cells was incubated in RLT buffer for 3min,
the mixture was gently vortexed, and the supernatant was
subjected to the RNA isolation procedure. The quality and
quantity of RNA was determined using the NanoDrop ND-
1000device(Nanodroptechnologies,Wilmington,Delaware,
USA). Contaminating genomic DNA was removed by diges-
tion with the RNase-free DNase Kit following the manufac-
turer’s protocol (Qiagen).
Each 250ng of RNA was reversely transcribed using an
Affinity script QPCR-cDNA synthesis kit (Stratagene, La Jolla,
CA, USA) following the manufacturer’s instructions.
Real time RT-PCR was performed on a Stratagene
MX3005P QPCR system (Stratagene, La Jolla, CA,
USA). PCR was performed using the primer assays for
human collagen-1 (COL1A, NM 000088, catalog number
PPH01299F), alkaline phosphatase (ALPL, NM 000478,
catalog number PAHS-026), core binding factor-1 (cbfa-1
also known as Runt-related transcription factor 2, RUNX2,
NM 004348.3, catalog number PPH01897B), osteocalcin
(BGLAP, bone gamma-carboxyglutamate (gla) protein,
NM 199173.3, catalog number PPH01898A), vascular
endothelial growth factor (VEGF, NM 003376.4, catalog
number PPH00251B), and von Willebrand factor (vWF,
NM 000552.3, catalog number PPH02567E); all purchased
from Biomol (SuperArray, Frederick, MD, USA). As
reference gene the expression of glyceraldehyde-3-phosphate
dehydrogenase (GAPDH, NM 002046.3, catalogue number
PPH00150E) was measured.
A melting curve analysis was applied to ensure the
specificity of the PCR reaction. Relative quantification of
the mRNA levels of the target genes was determined using
the comparative CT (threshold cycle values) method (2
−ΔCT
method).Theresultsare presentedas fold change to GAPDH
gene expression.
2.9.Statistics. Results are presented as mean values and stan-
dard error of mean (SEM). Kruskal-Wallis test with Dunn’s
post hoc test for multiplicity was used for comparisons
betweenthegroupsandfortheanalysisofchangesduringthe
follow-up period (day 2 versus day 6 and day 10). A 𝑃 value <
0.05 indicates statistical significance.
3. Results
3 . 1 .M S Ca n dE P CC h a r a c t e r i z a t i o n .EPC showed typical
ea r l yE P Cc h a r a ct e ri s ti c ss u c ha ss p i n dl e - s h a peda p pea r a n c e ,
DiLDL uptake, binding of UEA-1-lectin, and the expres-
sion of vWF and CD31 (Figures 1(a)–1(d)). MSC from all
donors had a fusiform and a spindle-shaped appearance and
demonstrated a typical pattern of surface markers (CD34−,
CD45−, CD71+, CD90+, CD105+). Moreover, osteogenic
differentiationwasinducibleasassessedbyvanKossastaining
(Figures 1(d) and 1(e)).
3.2. MSC and EPC Adherence to Tutoplast. The overall per-
centage of initially adhering cells ranged from 90% to 95%
and did not differ significantly between MSC and EPC.
Scanning electron microscopy images of Tutoplast 2d a y s
after cell seeding revealed a slightly roughened surface lack-
ing sharp edges (Figure 2(a)). Higher magnification revealed
a surface composed of a dense layer of fibrils (Figure 2(b)).
BothMSCandEPCappearedfirmlyattachedtotheTutoplast
s u r f a c e .W h i l eM S Ch a dab i g g e rs i z et h a nE P Ca n ds h o w e d
a flattened and spread-out appearance (Figure 2(d)), EPC
appeared elongated and spindle shaped (Figure 2(c)). In the
samples containing both MSC and EPC their district shapes
made it possible to differentiate between the 2 cell types on
the Tutoplast surface (Figure 2(e)).
3.3. Number of Adhering MSC and EPC on Tutoplast Surface.
In the samples containing both MSC and EPC, the number
of EPC declined significantly (𝑃 < 0.05) from day 2 to day 6
and then remained stable until day 10. This was also observed
in samples in which EPCs were incubated in the presence of
osteogenicsupplements.However,onday2afterseeding,the
numberofadheringEPCswassignificantlyhigherincultures
supplemented with osteogenic factors (Figure 3(a)).
The number of adhering MSCs also decreased signifi-
cantly (𝑃 < 0.05) from day 2 to days 6 and 10, independent of
the presence of osteogenic factors (Figure 3(b)).
3.4. MSC and EPC: Metabolic Activity. The MTT assay
demonstrated MSC and EPC metabolic activity over the
entire observation period. The number of adhering cells par-
alleled the metabolic activity of EPC, dropping significantly
(𝑃 < 0.05,Figur e4(a)) from day 2 to day 6. In the presence of
osteogenicsupplementsthemetabolicactivityofEPCslightly
increased in comparison to controls; however, this increase
was not statistically significant (Figure 4(a)).
The metabolic activity of MSC decreased slightly with
time, depicting a similar course as described for the number
of adhering MSCs. This decrease was not statistically sig-
nificant (Figure 4(b)). In contrast to EPC, when osteogenic
substances were added to MSC, metabolic activity was sig-
nificantly increased compared to the corresponding controls
on day 6 and day 10 (Figure 4(b)).
3.5. Endothelial Differentiation (DiLDL Uptake). The uptake
of acetylated low-density lipoprotein is an active process that
characterizes endothelial cells. Although a significant (𝑃<
0.05) decline of the DiLDL uptake was noted over the time,
a significant ability of EPC to uptake DiLDL was conserved
over the entire 10-day observation period (Figure 5(a)).
Using an exposure time of 0.25s the mean pixel brightness
decreased from 60.0 ± 5 . 5a td a y2t o3 4± 3.8 at day 10
(𝑃 < 0.05 versus day 2, Figures 5(a) and 5(c)).
Under osteogenic conditions the DiLDL uptake was
impaired on day 2 (trend: 𝑃 < 0.07)a n dd a y1 0( 𝑃 < 0.05)i nMediators of Inflammation 5
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Figure1:CharacterizationofEPC(a–c)andMSC(d,e).Representativeresultswereshown.EPCdemonstratedaspindle-shapedappearance
(a). The ability of EPC for DiLDL uptake (red color) and the binding of UEA-lectin-FITC (green color) are shown in (b). The image consists
of a superimposition of the FITC-fluorescence channel and the Rhodamine-fluorescence channel. Cells carrying both characteristics appear
in orange. The protein expression of vWF (c) and CD31 (PECAM, (c)) was assessed by flow cytometry (filled histograms demonstrate the
isotype control; black line indicates the antibody staining). The MSCs were characterized by flow cytometry (d); the cells were negative for
CD34 and CD45 and express CD73, CD90 (Thy-1), and CD105 (Endoglin, filled histogramms demonstrate the isotype control; black line
indicates the antibody staining). In (e) the ability of MSC for osteogenic differentiation was assessed by means of von Kossa staining.Th el e ft
image demonstrated the calcium deposition (black spots) under control conditions; the right image depicted the calcium deposition under
osteogenic culture conditions. Scale bars represent 50𝜇m( a ) ,1 0 0𝜇m( b ) ,a n d5 0 0𝜇m( e ) .6 Mediators of Inflammation
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Figure 2: Surface characteristics and direct proof of EPC and MSC on Tutoplast by SEM. (a) shows a Tutoplast granule without cells, (b) in a
higher magnification to demonstrate the fibrillar structure. (c), (d), and (e) show Tutoplast sown with EPC (c), with MSC (d), and with both
cell types in combination (e). Early EPC appeared rather spindle shaped and elongated whereas the MSC demonstrated a more flattened and
out-spread phenotype. Scanning electron microscopy was performed as described in the Materials and Methods Section. Bold type arrows
indicate MSC, and spotted arrows indicate EPC. The scale bar indicates 3𝜇m( b ) ,6 0𝜇m (c, d), and 100𝜇m (a, e), respectively.
comparison to the corresponding controls (Figures 5(b) and
5(c)).
In samples where MSC and EPC were cocultured the
mean pixel brightness between days 2 and 10 declined
significantly(𝑃 < 0.05,Figur e5(c)).H o w ever ,themea np ix el
brightnessonday2waslowerincomparisontoEPCcultured
alone on Tutoplast (37.1 ± 2.2 versus 60.0 ± 5.5, 𝑃 < 0.05,
Figure 5(c)).
In co-culture and under osteogenic conditions a com-
parable DiLDL fluorescence was observed, that declined
significantly over 10 days (𝑃 < 0.05,F i g u r e5(c),d a y2 :
37.0 ± 2.5, day 6: 30.5 ± 2.6, and day 10: 18.5 ± 2.0).
3.6. MSCandEPCDifferentiation(GeneExpressionAnalysis).
In order to assess MSC and EPC differentiation expression of
osteogenic genes (Collagen-1alpha, RUNX-2, BGLAP, ALP)
and endothelial marker genes (vWF, VEGF) were measured
on day 10. vWF gene expression significantly (𝑃 < 0.05)
increased when EPCs were cultured on Tutoplast versus the
culture on plastic (reference EPC) (Figure 6(a)). OsteogenicMediators of Inflammation 7
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Figure3:AdhesionofEPCandMSConTutoplast.ThenumberofadheringEPC(a)andMSC(b)cultivatedonTutoplast declinessignificantly
over the time independently of the presence of osteogenic substances.
∗: 𝑃 < 0.05.
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Figure4:MTTassay,metabolicactivityofEPC(a)andMSC(b)cultivatedonTutoplast.Presenceofosteogenicsubstancesleadtoasignificant
increase in MTT conversion in MSC. The metabolic activity was assessed using the MTT assay as described in Section 2.
∗: 𝑃 < 0.05.
stimulation of EPC led to a decrease in vWF gene expression
(𝑃 = 0.09,F i g u r e6(a)).
In contrast, VEGF gene expression was significantly
(𝑃 < 0.05)h i g h e ri nE P Cc u l t u r e do np l a s t i ca sw e l la so n
Tutoplast under osteogenic conditions versus EPC cultured
with Tutoplast alone (Figure 6(b)).
Collagen-1𝗼 and ALP gene expression was limited to
MSC whereas a slight gene expression of RUNX and BGLAP
was also observed in EPC independent from the culture
conditions. Collagen-1𝗼 gene expression on Tutoplast was
significantly (𝑃 < 0.05) reduced in comparison to refer-
ence MSC (Figure 6(c)). Osteogenic conditions lead to a
f u r t h e rs i g n i fi c a n tr e d u c t i o no fc o l l a g e n - 1 𝗼 gene expression
of MSC cultured on Tutoplast (𝑃 < 0.05,F i g u r e6(c)).
In contrast, a trend towards increased collagen expression
w a so b s e r v e di nc o c u l t u r ew i t hE P Ci nc o m p a r i s o nt oM S C
cultured on Tutoplast (𝑃 < 0.09). Furthermore, the collagen
gene expression in the coculture was significantly elevated
to MSC, respectively, and MSC and EPC cultured under
osteogenic conditions (𝑃 < 0.05,F i g u r e6(c)). Coculture
under osteogenic conditions expressed higher collagen level
in comparison to MSC under osteogenic conditions.
The gene expression of ALP (alkaline phosphatase) was
significantlyincreasedinreferenceMSCincomparisonMSC
cultured on Tutoplast (𝑃 < 0.05,F i g u r e6(d)).
No differences regarding the gene expression of BGLAP
(osteocalcin) and RUNX (cbfa1) between the groups were
observed (Figures 6(e) and 6(f)).8 Mediators of Inflammation
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Figure 5: EPC on Tutoplast, decline of DiLDL uptake over the observation period independently of the presence of osteogenic stimulation.
Representative images of day 2, day 6, and day 10 under control conditions (a) and osteogenic conditions (b), and data evaluations (c) were
shown.Parallelpreparationswereused.TheDiLDLstainingwasperformedonthedayofmeasurement.Thus,areducedDiLDLfluorescence
is not due to a fading effect but due to a reduced uptake of DiLDL. The exposure time was 0.25s. Scale bar indicates 100𝜇m.
4. Discussion
In the present study we demonstrated that EPC can be
cultured successfully on the processed human bone allograft
Tutoplast,a l o n ea n di nc o m b i n a t i o nw i t hM S C .
Ad e c l i n ei nt h en u m b e ro fE P C sa n de n d o t h e l i a lf u n c -
tion (DiLDL uptake) was observed over the observation
period but generally the endothelial properties measured
were maintained, but to a reduced level. The addition of
osteogenic substances and the coculture with MSC lead to an
impairment of endothelial characteristics.
ThenumberofadheringMSCsalsodeclinedsignificantly
over time whereas the metabolic activity increased signifi-
cantly with osteogenic stimulation. This was associated withMediators of Inflammation 9
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Figure 6: Expression of endothelial and osteogenic marker genes after 10 days on Tutoplast.Resultsofthereal-timeRT-PCRforvWFinEPC
(a),VEGFinEPCandMSC(b),collagen-1𝗼(c),alkalinephosphatase(ALP)(d),osteocalcin(BGLAP)(d),andthetranscriptionfactorcbfa-1
(RUNX) (e) in MSC are shown. Messenger RNA was isolated from either MSC, EPC, or MSC and EPC cultured on Tutoplast for 10 days.
Reference RNA derived from EPC and MSC cultured under normal conditions was analyzed as well. Five MSC lines, respectively, five EPC
lines were tested. Experiments were performed in duplicate. Gene expression was determined by the comparative ΔCt method as described
in Section 2. Data are expressed as mean ± SEM of fold change to GAPDH gene expression.
∗: 𝑃 < 0.05;$ :𝑃 < 0.05 coculture (osteogenic
conditions) versus MSC (osteogenic conditions).
a decrease of osteogenic differentiation (reduced collagen-1𝗼
gene expression) and an increase of VEGF gene expression.
4.1. Clinical Use of Cancellous Bone Allografts. In a recent
study the outcomes of treatment with processed cancellous
bone allografts (Tutoplast)v e r s u sa u t o l o g o u sb o n eg r a ft
obtained from the iliac crest were compared in patients
with comminuted distal radius fractures. Over 70% of the
patients had good to excellent outcomes in both groups [28].
This study demonstrated that processed human cancellous
bone allografts can be as effective as autologous bone grafts
for treating distal radius fractures [28]. In another study10 Mediators of Inflammation
cranioplasty using the Tutoplast technology for autogenic
bone processing was compared to conventional polymethyl-
methacrylate (PMMA) calvarial reconstruction. In general
comparableresultswereachievedwiththeautogenicbonebut
in young patients bone resorption occurred [29].
4.2. Role Surface Properties Play in Cell Adhesion and Func-
tion. ThefavourableresultswithTutoplast inclinicalsettings
attributed this effect to its “natural” surface characteristics.
Such a surface is thought to promote ingrowth, adherence,
and migration of bone forming and other supplementary
cells. Studiesanalyzingtheinfluenceofdifferentbiomaterials
on cellular function demonstrate that cell-to-cell and cell-to-
matrix interactions are key to bone formation [30, 31].
Ar e c e n tin vitro study demonstrated that different
methods of sterilizing bone grafts significantly alter MSC
adhesion, proliferation, and differentiation [24]. In a former
study and in the present study we confirm and extend
those findings. We found that the number and metabolic
activity of MSCs adhering to Tutoplast were superior to the
synthetic materials tested [20]. Our SEM analysis revealed
thatTutoplast’s surface,consistingofadensemeshofcollagen
fibrils (Figure 1(b)), is suitable for the adherence of MSC.
Niemeyer and colleagues reported a higher seeding effi-
c i e n c yo fM S Co nc o l l a g e n - 1s c a ff o l d sc o a t e dw i t hh y d r o xy a -
patite in comparison to a 𝗼-TCP matrix. They also observed
thatMSCculturedonthecollagenscaffolddisplayedahigher
geneexpressionofbonesialoprotein,BMP-2,ALP,andosteo-
calcin when compared to MSC cultured on uncoated 𝗼-TCP
[32]. We also found a significant improvement in adhesion
andmetabolicactivityofMSCculturedonacollagenscaffold
(Tutoplast) versus synthetic scaffolds such as 𝗽-TCP and 𝗼-
TCP [20].
4.3. EPC on Tutoplast. In the present study we observed
a significant decline in EPC adherence to Tutoplast over
t i m e .Th er e l a t i v en u m b e ro fa d h e r i n gc e l l s( a sa s s e s s e db y
fluorescence microscopy) was approximately halved over the
10-dayobservationperiod.DuringthesametimeperiodEPC
endothelial characteristics declined but persisted.
The observed decline of the DiLDL uptake was possibly
due to the cultivation medium used. In order to meet the
requirements of both EPC and MSC, that is, to maintain
endothelial differentiation of EPC and prevent endothelial
differentiation of MSC, the medium consisted of one part of
EGM + EGM2 singlequots and two parts of MesenCult.
The EGM2 singlequots contains various growth and
differentiating factors such as VEGF and insulin-like growth
factor(IGF).DuetotheadditionofMesenCult theconcentra-
tions of both factors were reduced to one third. Both factors
were necessary to maintain the state of differentiation of EPC
a n ds u p p o r tt h eD i L D Lu p t a k eo fE P C( V E G F :[ 33], IGF:
[34]). In previous work we demonstrated that MSC cultured
with this mixture did not express endothelial characteristics
with the exception of VEGF gene expression [25].
Interestingly, we observed a significant increase of vWF
g e n ee x p r e s s i o ni nE P Con Tutoplast,p e r h a p sd u et ot h e
collagensurrounding.Usamietal.aswellasSchmeisser et al.
cultured early EPC in collagen hydrogels for at least 14 days
and observed a significant vWF expression. However, no
comparisons to other matrices were performed [25, 35, 36].
To our knowledge no other report is available that describes
theregulationofearlyEPCcultivatedonadense3Dcollagen-
1𝗼 surface.
4.4. Effect of Osteogenic Conditions on MSC Cultured on
Tutoplast. I nt h ep r e s e n ts t u d yw eo b s e rv e dt h a tt h en u m b e r
of MSC was equal under osteogenic conditions; however,
their metabolic activity was significantly increased. This
l a t t e ro b s e r v a t i o nc o u l db ed u et ot h et r a n s f o r m a t i o nt o
an osteogenic phenotype which might be associated with
a raised biosynthesis of peptides. Interestingly, the increase
in metabolic activity was not accompanied by an elevated
gene expression of collagen-1𝗼. It was reported for dermal
fibroblasts that the collagen synthesis is negatively regulated
by interaction with collagen fibers via a certain collagen
receptor, and mesenchymal stem cells also express collagen
receptors [37, 38]. Thus, it is feasible to assume that the
collagen biosynthesis underlies a similar negative feedback
loop in MSC seeded onto Tutoplast.
4.5. Effect of Osteogenic Conditions on EPC Cultured on
Tutoplast. Osteogenic substances improve the bone forming
capacityofMSCbutmayharmtheendothelialdifferentiation
of EPC. Less information is available about the influence of
osteogenic differentiation on early EPC. The current study
demonstrated that the endothelial differentiation of early
EPC on Tutoplast is partly impaired under osteogenic con-
ditions. The DiLDL uptake was decreased under osteogenic
conditions, and the gene expression of vWF tended to
decline but remained still higher compared to reference EPC
cultivated on a fibronectin-coated surface. Gene expression
of VEGF tended to increase on Tutoplast under osteogenic
conditions. The perpetuation of an endothelial cell-like phe-
notype under osteogenic conditions underlines the missing
potential of early EPC for osteogenic transdifferentiation.
In one study the effect of osteogenic stimuli on CD133
expressing late EPC was evaluated. The authors described
a transformation to a osteogenic phenotype [39]. However
as described in the introduction those cells differ in many
respects from early EPC used in the present work (for review
[40]).
4.6.DifferentiationinCoculture,GeneExpressionAnalysis. In
coculture a significant decline of the vWF gene expression
w a so b s e r v e di nc o m p a r i s o nt oE P Cc u l t u r e da l o n eo n
Tutoplast. In coculture experiments a mixture consisting of
each 2.5 × 10
5 MSC and 2.5 × 10
5 EPC was seeded; in
single culture experiments 5 × 10
5 EPCs were used. Hence,
the number of EPCs was halved in comparison to single-
culture experiments. This may explain the decline of vWF
geneexpressionobservedincocultureexperiments.Sincethe
vWF-gene expression of MSC is rather neglectable (10% of
vWFgeneexpressioninEPC)[25],itisfeasibletoassumethat
EPCsarethemainproducersofvWFmRNAinourcoculture
experiments.Mediators of Inflammation 11
The collagen-1𝗼 expression was significantly enhanced
in coculture experiments. Since our own previous data
demonstrated that early EPCs do not express collagen-1𝗼
[25], the increase of collagen-1𝗼 mRNA could be attributed
to MSC.
The increase of collagen-1𝗼 g e n ee x p r e s s i o ni no u rc oc u l -
ture experiments might be due to a release of osteogenic sub-
stancesbyEPC.AsimilarobservationwasmadebyKaigleret
al. They described the osteogenic stimulationof MSCs which
were cocultured with endothelial cells and identified BMP2
releasedbytheendothelialcellsasaresponsiblefactorforthe
osteogenic differentiation [41].
With regard to our study it is feasible to assume that
early EPCs also release osteogenic substances (i.e., BMPs) or
substanceswhichfosterthecollagensynthesis(i.e.,TGF-𝗽)of
MSC. However, if early EPCs release BMP-2 and/or TGF-𝗽,
this is still not known.
5. Conclusion
The possibility for cell-based therapy of large bone defects
gains increased attention, and it has been demonstrated that
the combination of MSC and EPC leads to a superior bone
healing response in comparison to single-cell populations in
different animal models [5, 36]. Additionally, other studies
suggest an additional beneficial effect of an osteogenic dif-
ferentiation of the MSC prior the implantation to the host
[6–8]. However, less attention has been drawn to the carrier
material to immobilize regenerative cells to the defect zone.
Recentstudiesofourgroupsuggestthatprocessedcancellous
bone chips are superior to synthetic bone grafts in terms of
adhesion and function of MSC [20].
The current study extends those findings. The study
provides evidence that the combined cultivation of two types
of progenitor cells on a mineralized bone matrix for the
p u r p o s eo ft i s s u ee n g i n e e r i n gi st e c h n i c a l l yp o s s i b l e .Th e
early EPCs maintain endothelial differentiation even under
osteogenic conditions though endothelial activity was found
tobereduced.Moreover,ourresultssuggestthatconcomitant
early EPCs stabilize the collagen-1𝗼 synthesis of MSC which
might be beneficial in bone healing. However, wether MSC
and EPC seeded together on a cancellous bone granules
improve the bone healing has to be proved in experimental
bone healing models.
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